Global Pharmacogenomics Technology (Theranostics & CDx) Market Growth (Status and Outlook) 2025-2031

The global Pharmacogenomics Technology (Theranostics & CDx) market size is predicted to grow from US$ 12320 million in 2025 to US$ 28870 million in 2031; it is expected to grow at a CAGR of 15.2% from 2025 to 2031.

Pharmacogenomics Technology (Theranostics & CDx) manufacturers include Illumina, Roche and Agilent etc. The top 3 company holds a share of more than 50%. North America takes up the largest sales market, with a share of more than 40%, followed by Europe and China, with the share of about 30% and 10% respectively.

LPI (LP Information)' newest research report, the “Pharmacogenomics Technology (Theranostics & CDx) Industry Forecast” looks at past sales and reviews total world Pharmacogenomics Technology (Theranostics & CDx) sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmacogenomics Technology (Theranostics & CDx) sales for 2025 through 2031. With Pharmacogenomics Technology (Theranostics & CDx) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmacogenomics Technology (Theranostics & CDx) industry.

This Insight Report provides a comprehensive analysis of the global Pharmacogenomics Technology (Theranostics & CDx) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmacogenomics Technology (Theranostics & CDx) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmacogenomics Technology (Theranostics & CDx) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmacogenomics Technology (Theranostics & CDx) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmacogenomics Technology (Theranostics & CDx).

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmacogenomics Technology (Theranostics & CDx) market by product type, application, key players and key regions and countries.

Segmentation by Type:
Instrument
Reagents and Consumables
Others

Segmentation by Application:
Tumor
Diabetes
Mental Diseases
Cardiovascular Diseases
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Roche
Agilent
Abbott
Thermofisher
Qiagen
Guardant Health
MGI Tech Co., Ltd.
Amoydx Biology
Genomics

Please note: The report will take approximately 2 business days to prepare and deliver.